ASCENDIS PHARMA A/S — Credit Rating and Financial Key Figures
CVR number: 29918791
Tuborg Boulevard 12, 2900 Hellerup
tel: 36944486
Income statement (mEUR)
2019 | 2022 | 2023 | |
---|---|---|---|
Fiscal period length | 12 | 12 | 12 |
Net sales | 40.45 | 105.37 | 302.71 |
Costs of manufacturing | -13.86 | -51.94 | |
Gross profit | 40.45 | 91.51 | 250.77 |
Costs of marketing | - 134.17 | - 178.94 | |
Other operating expenses | - 122.15 | - 135.29 | -75.03 |
EBIT | -81.71 | - 177.95 | -3.19 |
Other financial income | 28.07 | 82.24 | 77.62 |
Other financial expenses | -0.84 | -47.37 | -34.71 |
Pre-tax profit | -54.48 | - 143.08 | 39.72 |
Income taxes | -0.95 | 0.18 | -0.00 |
Net earnings | -55.43 | - 142.90 | 39.72 |
Assets (mEUR)
2019 | |
---|---|
Intangible assets total | |
Other tangible assets | 11.75 |
Tangible assets total | 11.75 |
Holdings in group member companies | 48.60 |
Investments total | 48.60 |
Non-curr. owed by group member comp. | 497.16 |
Non-current other receivables | 0.95 |
Long term receivables total | 498.11 |
Inventories total | |
Prepayments and accrued income | 1.05 |
Current other receivables | 3.18 |
Short term receivables total | 4.23 |
Cash and bank deposits | 567.11 |
Cash and cash equivalents | 567.11 |
Balance sheet total (assets) | 1 129.80 |
Equity and liabilities (mEUR)
2019 | 2022 | 2023 | |
---|---|---|---|
Share capital | 6.44 | ||
Other reserves | 1 059.39 | ||
Retained earnings | 55.43 | 142.90 | -39.72 |
Profit of the financial year | -55.43 | - 142.90 | 39.72 |
Shareholders equity total | 1 065.83 | ||
Non-current loans from credit institutions | 8.71 | ||
Non-current other liabilities | 0.91 | ||
Non-current liabilities total | 9.62 | ||
Current leasing loans | 2.05 | ||
Current owed to group member | 15.53 | ||
Other non-interest bearing current liabilities | 28.76 | ||
Accruals and deferred income | 8.01 | ||
Current liabilities total | 54.35 | ||
Balance sheet total (liabilities) | 1 129.80 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.